FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,117 letters match. Newest first.

  1. Guangzhou Four E’s Scientific Co., Ltd.

    FDA warns Guangzhou Four E’s over CGMP failures for OTC drugs, including a sterile-labeled product with inadequate sterility assurance.

    High risk
  2. Knickerbocker 365 Inc.

    FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.

    High risk
  3. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk
  4. Zhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.

    FDA warns Zhejiang Uniquality over inadequate OTC drug component testing and quality oversight; import alert issued.

    High risk
  5. Mena Food Group, LLC

    FDA says Mena Food Group made ready-to-eat bakery products under insanitary conditions and without allergen or CGMP controls.

    High risk
  6. Catwalk Cosmetic Laboratories Pty Ltd.

    FDA warns South African over-the-counter drug maker Catwalk Cosmetic Laboratories of current good manufacturing practice violations and import alert.

    High risk
  7. Eurosirel S.P.A

    FDA warns Eurosirel over CGMP failures in topical drugs and pain patches, including missing glycerin identity testing.

    High risk
  8. Hangzhou Huiji Biotechnology Co., Ltd.

    FDA warned Hangzhou Huiji Biotechnology over CGMP failures in OTC hand sanitizers, including missing glycerin and ethanol safety tests.

    High risk
  9. Grupo VPAS C.A.

    FDA warns Venezuela seafood processor Grupo VPAS over inadequate seafood safety plan controls for histamine and ciguatera in frozen Medregal fillets.

    High risk
  10. Maruhachi Muramatsu Inc., Danchi Factory

    FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

    High risk
  11. Adept Medical Ltd.

    Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.

    High risk
  12. Kyokuyo Global Seafoods Co. LTD.

    FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.

    High risk
  13. Procesadora Vikingo C.A.

    FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.

    High risk
  14. Originitalia SRL

    FDA warns Originitalia SRL over manufacturing quality failures in OTC drugs, including untested active ingredient and missing release testing.

    High risk
  15. Unexo Lifesciences, Private Limited

    FDA warned Unexo Lifesciences over serious CGMP violations, including data integrity failures and torn batch records for U.S.-bound drugs.

    High risk
  16. Colgate-Palmolive/Tom's of Maine, Inc.

    FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.

    High risk
  17. Frontier Biologics, LLC

    FDA warned Frontier Biologics of Waco, Texas, that its amniotic fluid and membrane products are unapproved drugs and unlicensed biologics.

    High risk
  18. Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.

    FDA cited Tianjin Darentang Jingwanhong Pharmaceutical for limiting a drug inspection and manufacturing violations at its China plant.

    High risk
  19. Golden Shrimp Seafood Joint Stock Company

    Golden Shrimp Seafood's frozen yellowfin tuna had an inadequate seafood safety plan for controlling histamine.

    High risk
  20. Zhejiang Qimei Cosmetics Co., Ltd.

    Zhejiang Qimei Cosmetics drew an FDA warning for CGMP violations in sterile-labeled OTC isopropyl alcohol prep pads.

    High risk
  21. Multaler et Cie SAS

    FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.

    High risk
  22. Owens & Minor, Inc. dba American Contract Systems, Inc.

    FDA warned Owens & Minor unit American Contract Systems over device quality-system violations for sterile kits, including failed sterilization bags and incomplete design verification.

    High risk
  23. Rongcheng Jiayuan Food Co., Ltd

    FDA says Rongcheng Jiayuan's canned tuna is adulterated due to seafood HACCP and low-acid canned food violations.

    High risk
  24. Rolence Ent. Inc.

    FDA warns Rolence Ent. Inc. over quality system and MDR failures for its XR-01 Portable X-ray System.

    High risk
  25. Micro-X Ltd.

    FDA warns Australia's Micro-X over design, CAPA and complaint failures on Rover mobile x-ray systems, plus unreported field corrections.

    High risk
  26. Analytical Food Laboratories, Inc.

    FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.

    High risk
  27. Top Health Manufacturing, LLC

    Top Health Manufacturing's dietary supplements violated manufacturing and labeling rules, FDA says.

    Medium
  28. Argon Medical Productions & Vertrieb Gesellschaft MBH & CO

    FDA warns Argon Medical over dental implant quality-system failures, unreported injuries, and missing unique device identifier labeling.

    High risk
  29. MedOffice Saglik Endustri Anonim Sirketi

    FDA warned MedOffice Saglik after an inspection found missing batch release testing and inadequate process validation for over-the-counter drugs.

    High risk
  30. Choice All Natural, Inc. dba Om Botanical

    FDA warns Om Botanical of Apex, NC over filthy manufacturing, an unapproved rash cream, and lapsed FDA registration.

    High risk
  31. Diora Kimya Sanayi ve Ticaret Limited Sirketi

    FDA cited Diora Kimya for drug manufacturing quality failures and for an unlisted antibacterial soap.

    High risk
  32. Soliteint Kozmetikai KFT

    Hungarian contract maker Soliteint Kozmetikai failed to test OTC pain-relief drugs and ingredients, FDA says; U.S. production halted.

    High risk
  33. Omni Lens Pvt. Ltd.

    FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.

    High risk
  34. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  35. Amnio Technology, LLC

    FDA warned Amnio Technology over unapproved injectable amniotic products and serious manufacturing deviations at its Phoenix facility.

    High risk
  36. Hemarus LLC

    Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.

    High risk
  37. Bacalao Giraldo, S.L.U.

    FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.

    High risk
  38. Outin Futures Corp.

    FDA warned Outin Futures, a Korean drug manufacturer, of CGMP violations and sunscreen misbranding after a March 2024 inspection.

    High risk
  39. Alfred Louie, Inc.

    Alfred Louie, Inc. lacked allergen, mycotoxin and metal controls for fresh noodles and mislabeled wheat, FDA says.

    High risk
  40. Procesadora Marina De La Costa Oriental Del Lago C.A.

    FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.

    High risk
  41. MMC Healthcare Ltd.

    FDA warned MMC Healthcare Ltd. in Chennai that its drug products violate manufacturing rules, citing backdated records, weak computer controls, and unvalidated test methods.

    High risk
  42. Supercore Products Group, Inc.

    FDA warns Supercore that Hard Steel and Gold Hard Steel Plus are unapproved, mislabeled drugs with hidden sildenafil; Hard Steel also has acetaminophen.

    High risk
  43. Makra Kozmetika D.O.O.

    FDA warns Makra Kozmetika over OTC drug manufacturing violations, including missing batch and ingredient testing, after April 2024 inspection.

    High risk
  44. Ice Cream House LLC

    Ice Cream House LLC's Brooklyn ice cream plant held a resident Listeria strain tied to a 2023 outbreak, FDA says.

    High risk
  45. Little Moon Essentials, LLC

    FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.

    High risk
  46. Far East Summit LLC

    FDA says Far East Summit sold herbal supplements as unapproved drugs and made them under serious manufacturing violations.

    High risk
  47. Diamond Chemical Co., Inc.

    Diamond Chemical Co. in East Rutherford, NJ, made OTC hand sanitizers without required ingredient and finished-product testing or process validation.

    High risk
  48. Clean Solutions LLC

    FDA warned Clean Solutions LLC that its OTC hand soaps and sanitizer were adulterated because it released drugs without component or finished-product testing.

    High risk
  49. NRS Enterprises, Inc. d/b/a Sunflour Bakery

    FDA found Sunflour Bakery's ready-to-eat baked goods made under insanitary conditions, with allergen, pest, and food-safety-plan failures.

    High risk
  50. Azurity Pharmaceuticals, Inc.

    FDA warned Azurity Pharmaceuticals over unapproved FIRST drug kits and manufacturing quality failures at its Wilmington, MA plant.

    High risk